1177
COM:SINOBIOPHARM
Sino Biopharmaceutical Limited
- Stock
Last Close
3.38
22/11 08:08
Market Cap
51.89B
Beta: -
Volume Today
42.39M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 552.54M - | 675.14M 22.19% | 758.31M 12.32% | 845.14M 11.45% | 906.73M 7.29% | 1.06B 17.34% | 1.43B 34.76% | 1.77B 23.39% | 1.91B 7.89% | 2.13B 11.76% | 2.16B 1.31% | |
average payables | 306.69M - | 495.54M 61.58% | 631.34M 27.40% | 734.52M 16.34% | 877.44M 19.46% | 1.38B 57.32% | 1.82B 31.91% | 1.88B 3.18% | 1.82B 3.10% | 1.67B 8.53% | 1.49B 10.76% | |
average receivables | 0.00 - | 0.00 0% | 4.58B - | |||||||||
book value per share | 0.26 - | 0.48 84.93% | 0.39 18.09% | 0.48 22.49% | 0.55 15.76% | 1.57 185.23% | 1.65 5.01% | 0.89 46.14% | 1.61 81.18% | 1.60 1.02% | 1.64 2.96% | |
capex per share | -0.03 - | -0.05 68.16% | -0.07 46.19% | -0.06 16.45% | -0.09 56.13% | -0.09 4.23% | -0.09 1.01% | -0.10 7.28% | -0.10 2.05% | -0.09 9.24% | ||
capex to depreciation | -2.60 - | -2.46 5.46% | -3.78 53.80% | -2.65 30.00% | -4.25 60.54% | -1.44 66.15% | -1.18 17.82% | -1.12 5.01% | -1.91 69.85% | -1.63 14.63% | ||
capex to operating cash flow | -0.37 - | -0.28 24.94% | -0.58 110.28% | -0.30 48.15% | -0.39 29.29% | -0.33 15.06% | -0.33 1.99% | -0.35 7.21% | -0.35 1.10% | -0.27 22.87% | ||
capex to revenue | -0.06 - | -0.05 12.37% | -0.09 78.15% | -0.07 28.16% | -0.10 49.29% | -0.08 17.76% | -0.07 11.71% | -0.08 9.88% | -0.07 10.32% | -0.06 15.95% | ||
cash per share | 0.15 - | 0.36 145.89% | 0.28 21.90% | 0.51 83.03% | 0.59 15.57% | 0.70 18.22% | 1.02 44.66% | 0.87 13.95% | 0.84 3.72% | 0.91 7.98% | 0.68 25.37% | |
days of inventory on hand | 131.91 - | 112.68 14.58% | 106.72 5.29% | 110.81 3.83% | 108.51 2.07% | 105.16 3.09% | 122.89 16.86% | 132.42 7.75% | 132.64 0.17% | 146.67 10.57% | 145.82 0.58% | |
days payables outstanding | 77.80 - | 96.89 24.53% | 86.21 11.02% | 102.34 18.70% | 109.67 7.16% | 159.34 45.29% | 134.07 15.86% | 137.19 2.33% | 115.90 15.52% | 103.12 11.03% | 97.63 5.32% | |
days sales outstanding | 0.00 - | 62.83 - | ||||||||||
debt to assets | -0.00 - | 0.12 5,603.69% | 0.10 13.95% | 0.17 58.20% | 0.14 14.91% | 0.07 51.37% | 0.15 115.58% | 0.30 103.66% | 0.20 33.50% | 0.22 9.04% | 0.20 9.89% | |
debt to equity | -0.00 - | 0.26 6,590.60% | 0.22 14.65% | 0.38 72.09% | 0.32 16.32% | 0.12 63.55% | 0.28 137.06% | 0.85 206.39% | 0.40 52.85% | 0.47 17.50% | 0.41 12.67% | |
dividend yield | 0.01 - | 0.01 69.78% | 0.01 58.84% | 0.01 92.55% | 0.01 51.60% | 0.01 140.68% | 0.01 47.44% | 0.01 48.08% | 0.01 12.76% | 0.02 48.83% | ||
earnings yield | 0.03 - | 0.07 90.62% | 0.03 47.58% | 0.05 38.08% | 0.03 45.72% | 0.16 535.32% | 0.04 76.36% | 0.04 5.45% | 0.17 380.00% | 0.07 62.27% | 0.03 51.89% | |
enterprise value | 21.47B - | 17.39B 18.99% | 42.89B 146.55% | 35.83B 16.45% | 83.97B 134.33% | 52.74B 37.19% | 119.96B 127.47% | 122.87B 2.43% | 86.15B 29.88% | 81.23B 5.72% | 61.32B 24.52% | |
enterprise value over ebitda | 11.83 - | 7.11 39.87% | 13.32 87.30% | 9.47 28.86% | 18.59 96.17% | 8.58 53.86% | 16.49 92.29% | 18.78 13.87% | 4.34 76.89% | 10.50 141.92% | 9.72 7.41% | |
ev to operating cash flow | 17.44 - | 9.46 45.76% | 22.36 136.42% | 11.59 48.15% | 22.50 94.05% | 10.35 53.98% | 22.53 117.63% | 23.07 2.41% | 16.05 30.42% | 12.97 19.24% | ||
ev to sales | 2.78 - | 1.76 36.68% | 3.52 100.29% | 2.53 28.16% | 5.67 124.07% | 2.52 55.44% | 4.95 96.07% | 5.20 4.97% | 3.21 38.27% | 2.82 12.00% | 2.34 17.08% | |
free cash flow per share | 0.05 - | 0.12 156.83% | 0.05 59.93% | 0.13 169.88% | 0.14 5.42% | 0.18 34.60% | 0.19 4.08% | 0.18 3.41% | 0.19 0.35% | 0.24 32.34% | ||
free cash flow yield | 0.03 - | 0.07 118.52% | 0.02 74.40% | 0.06 223.98% | 0.03 54.84% | 0.06 128.23% | 0.03 51.92% | 0.03 1.29% | 0.04 42.88% | 0.06 44.69% | ||
graham net net | 0.04 - | 0.01 79.66% | 0.00 81.69% | 0.08 5,704.16% | 0.12 55.03% | 0.08 38.43% | 0.10 35.57% | -0.39 486.60% | -0.32 18.30% | -0.43 33.82% | -0.46 6.20% | |
graham number | 0.53 - | 1.08 103.55% | 0.88 18.02% | 1.05 18.70% | 1.27 21.11% | 4.16 226.90% | 3.05 26.70% | 2.15 29.41% | 5.32 147.14% | 3.11 41.55% | 1.92 38.19% | |
income quality | 0.74 - | 0.82 11.32% | 0.67 19.00% | 0.92 38.64% | 0.89 3.53% | 0.45 49.89% | 0.95 113.93% | 1.06 11.40% | 0.29 72.80% | 1.08 275.24% | ||
intangibles to total assets | 0.01 - | 0.02 31.79% | 0.02 2.57% | 0.02 18.54% | 0.01 3.80% | 0.45 2,935.85% | 0.39 12.37% | 0.05 87.84% | 0.03 40.61% | 0.03 5.68% | 0.05 53.05% | |
interest coverage | 1.12K - | 58.18 94.82% | 40.07 31.12% | 58.79 46.69% | 53.56 8.90% | 32.45 39.41% | 25.26 22.16% | 15.12 40.15% | 61.11 304.26% | 15.24 75.07% | ||
interest debt per share | -0.00 - | 0.13 13,977.22% | 0.09 28.65% | 0.19 106.78% | 0.18 3.13% | 0.19 5.84% | 0.47 144.61% | 0.77 64.39% | 0.66 14.35% | 0.77 16.97% | 0.68 12.82% | |
inventory turnover | 2.77 - | 3.24 17.07% | 3.42 5.59% | 3.29 3.69% | 3.36 2.11% | 3.47 3.19% | 2.97 14.43% | 2.76 7.19% | 2.75 0.17% | 2.49 9.56% | 2.50 0.58% | |
invested capital | -0.00 - | 0.26 6,590.60% | 0.22 14.65% | 0.38 72.09% | 0.32 16.32% | 0.12 63.55% | 0.28 137.06% | 0.85 206.39% | 0.40 52.85% | 0.47 17.50% | 0.41 12.67% | |
market cap | 23.67B - | 18.55B 21.64% | 43.56B 134.84% | 36.29B 16.70% | 84.71B 133.45% | 55.56B 34.41% | 121.98B 119.54% | 119.29B 2.21% | 83.64B 29.89% | 75.90B 9.25% | 58.26B 23.24% | |
net current asset value | 2.41B - | 2.27B 5.90% | 3.26B 43.92% | 5.02B 53.98% | 5.46B 8.60% | 6.31B 15.61% | 6.90B 9.37% | -2.00B 128.94% | 688.86M 134.50% | -185.83M 126.98% | -1.63B 776.78% | |
net debt to ebitda | -1.21 - | -0.47 61.07% | -0.21 55.64% | -0.12 42.68% | -0.16 36.68% | -0.46 179.88% | -0.28 39.64% | 0.55 297.80% | 0.13 76.86% | 0.69 442.85% | 0.48 29.61% | |
net income per share | 0.05 - | 0.11 124.04% | 0.09 17.94% | 0.10 15.02% | 0.13 26.72% | 0.49 274.66% | 0.25 48.83% | 0.23 7.48% | 0.78 237.11% | 0.27 65.49% | 0.10 62.89% | |
operating cash flow per share | 0.07 - | 0.17 124.04% | 0.12 30.48% | 0.19 61.14% | 0.22 20.76% | 0.27 22.72% | 0.28 3.06% | 0.28 0.07% | 0.29 0.94% | 0.34 17.67% | ||
payables turnover | 4.69 - | 3.77 19.70% | 4.23 12.38% | 3.57 15.76% | 3.33 6.68% | 2.29 31.17% | 2.72 18.85% | 2.66 2.27% | 3.15 18.36% | 3.54 12.40% | 3.74 5.62% | |
receivables turnover | 12775.92T - | 5.81 - | ||||||||||
research and ddevelopement to revenue | 0.11 - | 0.10 7.03% | 0.10 1.10% | 0.11 12.22% | 0.17 - | |||||||
return on tangible assets | 0.11 - | 0.11 3.21% | 0.11 0.96% | 0.09 13.98% | 0.11 11.26% | 0.33 212.17% | 0.13 59.72% | 0.10 27.06% | 0.25 157.21% | 0.08 67.58% | 0.03 62.19% | |
revenue per share | 0.46 - | 0.89 91.90% | 0.73 17.94% | 0.85 16.30% | 0.89 4.58% | 1.13 26.74% | 1.29 14.40% | 1.26 2.37% | 1.43 13.78% | 1.55 7.99% | 1.41 8.51% | |
roe | 0.19 - | 0.23 21.15% | 0.23 0.19% | 0.22 6.10% | 0.24 9.47% | 0.31 31.36% | 0.15 51.27% | 0.26 71.78% | 0.48 86.07% | 0.17 65.13% | 0.06 63.96% | |
roic | 0.43 - | 0.25 40.85% | 0.29 12.44% | 0.36 28.00% | 0.30 18.10% | 0.14 52.11% | 0.12 14.28% | 0.14 10.37% | 0.39 191.10% | 0.13 66.70% | 0.11 17.82% | |
sales general and administrative to revenue | 0.06 - | 0.07 3.38% | 0.08 27.26% | 0.08 9.51% | 0.07 13.22% | 0.10 57.39% | 0.11 1.93% | 0.11 5.12% | 0.08 27.57% | 0.08 5.84% | 0.07 6.66% | |
shareholders equity per share | 0.26 - | 0.48 84.93% | 0.39 18.09% | 0.48 22.49% | 0.55 15.76% | 1.57 185.23% | 1.65 5.01% | 0.89 46.14% | 1.61 81.18% | 1.60 1.02% | 1.64 2.96% | |
stock based compensation to revenue | 0.00 - | 0.00 33.02% | ||||||||||
tangible asset value | 5.53B - | 6.83B 23.53% | 8.49B 24.18% | 10.41B 22.65% | 12.30B 18.21% | 15.30B 24.39% | 17.45B 14.05% | 20.17B 15.58% | 36.02B 78.55% | 36.03B 0.03% | 35.26B 2.13% | |
tangible book value per share | 0.33 - | 0.61 85.29% | 0.51 17.21% | 0.62 22.65% | 0.74 18.21% | 0.83 11.84% | 0.93 12.46% | 1.07 15.64% | 1.92 78.85% | 1.93 0.82% | 1.90 1.64% | |
working capital | 2.54B - | 3.45B 36.13% | 3.69B 6.96% | 7.07B 91.44% | 8.09B 14.41% | 8.87B 9.61% | 16.79B 89.30% | 11.85B 29.42% | 8.16B 31.16% | 5.78B 29.10% | 1.20B 79.28% |
All numbers in (except ratios and percentages)